Pascale Bouillé

Flash Therapeutics



Pascale Bouillé, PHD, CEO of Flash Therapeutics, was initially involved in fundamental research in retrovirology and has worked in a number of government and biotechnology research laboratories before creating Vectalys in 2005. She has built up over 15 years' experience in R&D projects in the fields of drug discovery and virology. Bouillé has conducted gene therapy trials for the Genethon laboratories with Dr. Olivier Danos and implemented the transition of viral vector tools from a technology-based to a commercially oriented product with Vectalys.